Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
In comparison, the placebo group experienced a weight loss of only 2.4%, or around 6 pounds, after 68 weeks
Results vary depending on individual factors such as diet, exercise regimen, and metabolism
[14] Tirzepatide, as a dual GIP/GLP-1 receptor agonist, may achieve higher weight reductions (15-22%) but is currently licensed only for diabetes in the UK
4.46, I 2 81%/ FPG = -23.4 mg/dL, 95% CI -29
Most patients self-administer their weekly injections at home after completing in-office training
US$ 25.82
US$ 20.66
US$ 27.59
US$ 29.85
US$ 25.44
US$ 23.87
US$ 28.05
US$ 22.19
US$ 22.77
US$ 28.88
US$ 26.84
US$ 26.72
US$ 28.93
